Pfizer/BioNTech, Moderna COVID vaccines backed for full approval in EU by EMA panel

Sep. 16, 2022 6:56 AM ETModerna, Inc. (MRNA), PFE, BNTXBy: Ravikash, SA News Editor5 Comments

European Union flag against European Parliament


A committee of the European Medicines Agency (EMA) recommended converting the conditional marketing authorizations (CMA) of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) Comirnaty and Moderna's (NASDAQ:MRNA) Spikevax COVID-19 vaccines into standard marketing authorizations.

The EMA's Committee for Medicinal Products for Human Use (CHMP) said this recommendation

Recommended For You

Comments (5)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.